AERD
Showing 1 - 25 of 33
AERD - Aspirin Exacerbated Respiratory Disease Trial in Vienna (Dupilumab)
Recruiting
- AERD - Aspirin Exacerbated Respiratory Disease
-
Vienna, AustriaMedical University of Vienna
Apr 5, 2022
AERD - Aspirin Exacerbated Respiratory Disease Trial in Kraków (Aspirin 300 Mg Oral Tablet, Placebo)
Recruiting
- AERD - Aspirin Exacerbated Respiratory Disease
- Aspirin 300 Mg Oral Tablet
- Placebo
-
Kraków, PolandUniversity Hospital, Pulmunology Clinic
Apr 4, 2023
Asthma, Aspirin-Induced Trial in United States (Ifetroban Oral Capsule, Placebo Oral Capsule)
Active, not recruiting
- Asthma, Aspirin-Induced
- Ifetroban Oral Capsule
- Placebo Oral Capsule
-
Tucson, Arizona
- +15 more
Nov 16, 2022
Aspirin-exacerbated Respiratory Disease Trial (Dupilumab, Placebo)
Not yet recruiting
- Aspirin-exacerbated Respiratory Disease
- Dupilumab
- Placebo
- (no location specified)
Aug 31, 2021
Genetics and Genomics of Aspirin Exacerbated Respiratory Disease
Suspended
- Aspirin Exacerbated Respiratory Disease
- +2 more
-
Denver, ColoradoNational Jewish Health
Aug 30, 2021
Chronic Rhinosinusitis With Nasal Polyps, Aspirin-exacerbated Respiratory Disease Trial in London (Celecoxib, Placebo)
Recruiting
- Chronic Rhinosinusitis With Nasal Polyps
- Aspirin-exacerbated Respiratory Disease
- Celecoxib
- Placebo
-
London, Ontario, CanadaSt. Joseph's Healthcare London
Apr 5, 2022
Aspirin-exacerbated Respiratory Disease Trial in Rochester (Dupilumab)
Completed
- Aspirin-exacerbated Respiratory Disease
-
Rochester, New YorkRochester Regional Health - Allergy/Immunology
Aug 25, 2020
Aspirin Sensitivity Trial in Cleveland (Omalizumab, )
Nasal Polyps, Asthma, Aspirin-Induced, Aspirin-exacerbated Respiratory Disease Trial in Boston (Ifetroban, Placebo)
Active, not recruiting
- Nasal Polyps
- +3 more
- Ifetroban
- Placebo
-
Boston, MassachusettsAsthma Research Center, Brigham and Women's Hospital
Oct 7, 2022
Nasal Polyps, Asthma, Aspirin-Induced, Aspirin-Exacerbated Respiratory Disease Trial in Boston (Dupilumab, Placebo)
Not yet recruiting
- Nasal Polyps
- +3 more
- Dupilumab
- Placebo
-
Boston, MassachusettsBrigham and Women's Hospital
Oct 7, 2022
IL-5R Signaling in Non-eosinophil Upper Airway Cells in CRSwNP
Recruiting
- Nasal Polyps
- Aspirin-exacerbated Respiratory Disease
- Non-Interventional
-
Boston, MassachusettsBrigham and Women's Hospital
Jan 5, 2023
Aspirin Hypersensitivity in Aspirin Exacerbated Respiratory
Active, not recruiting
- Asthma, Aspirin-induced
-
Bronx, New YorkMontefiore Medical Center
Jan 13, 2022
Aspirin-exacerbated Respiratory Disease, Sleep Trial in Mexico City (Endoscopic sinus surgery)
Unknown status
- Aspirin-exacerbated Respiratory Disease
- Sleep
- Endoscopic sinus surgery
-
Mexico City, Ciudad DE Mexico, MexicoInstituto Nacional de Enfermedades Respiratorias
Feb 6, 2019
Aspirin Exacerbated Respiratory Disease, Chronic Rhinitis Trial in Vienna (Microbiome swabs)
Completed
- Aspirin Exacerbated Respiratory Disease
- Chronic Rhinitis
- Microbiome swabs
-
Vienna, AustriaMedical University of Vienna
Aug 31, 2021
The Metabolomics of Anaphylaxis
Withdrawn
- Patients With AERD Undergoing Aspirin Desensitization
-
Boston, MassachusettsMassachusetts General Hospital - Allergy Associates
Mar 5, 2019
Chronic Rhinosinusitis With Nasal Polyps Trial in Worldwide (Experimental: Tezepelumab, Placebo)
Recruiting
- Chronic Rhinosinusitis With Nasal Polyps
- Experimental: Tezepelumab
- Placebo
-
Birmingham, Alabama
- +137 more
Jan 4, 2023
Aspirin-exacerbated Respiratory Disease, Aspirin-Sensitive Asthma With Nasal Polyps, Samter's Syndrome Trial in Mexico City (Low
Unknown status
- Aspirin-exacerbated Respiratory Disease
- +3 more
- Low salycilate diet
-
Mexico City, Ciudad DE Mexico, MexicoInstituto Nacional de Enfermedades Respiratorias
Jun 3, 2019
Role of Inflammatory Mediators in AERD
Unknown status
- Asthma, Aspirin-Induced
-
Boston, MassachusettsBrigham and Women's Hospital
Jan 14, 2019
Nasal Polyps, Staphylococcus Aureus Trial (Dupilumab Prefilled Syringe)
Not yet recruiting
- Nasal Polyps
- Staphylococcus Aureus
- Dupilumab Prefilled Syringe
- (no location specified)
Jun 20, 2022
Nasal Polyps in and Without Aspirin-exacerbated Respiratory
Completed
- Polyp Sinus
- biopsy
-
Vienna, AustriaMedical University of Vienna
Jan 24, 2020
ASA Triad, Asthma, Nasal Polyps, And Aspirin Intolerance Trial in Boston (Restricting daily intake of omega-6 fatty acids to
Completed
- ASA Triad
- Asthma, Nasal Polyps, And Aspirin Intolerance
- Restricting daily intake of omega-6 fatty acids to less than 4 grams and increasing omega-3 fatty acids to 3 grams
-
Boston, MassachusettsBrigham and Women's Hospital
Jan 14, 2019
Montelukast, Chronic Rhinosinusitis With Nasal Polyps Trial in Assiut (Montelukast, Prednisolone, Fluticasone Furoate)
Active, not recruiting
- Montelukast
- Chronic Rhinosinusitis With Nasal Polyps
- Montelukast
- +2 more
-
Assiut, EgyptAssiut University Hospital
Mar 6, 2022
Asthma, Aspirin-Induced, Aspirin Exacerbated Asthma Trial in Boston (Placebo Oral Tablet, Prasugrel Oral Tablet)
Completed
- Asthma, Aspirin-Induced
- Aspirin Exacerbated Asthma
- Placebo Oral Tablet
- Prasugrel Oral Tablet
-
Boston, MassachusettsAsthma Research Center
Sep 4, 2019
Chronic Rhinosinusitis (Diagnosis) Trial in Helsinki (Placebo Oral Tablet, Acetyl Salicylic Acid)
Recruiting
- Chronic Rhinosinusitis (Diagnosis)
- Placebo Oral Tablet
- Acetyl Salicylic Acid
-
Helsinki, FinlandHelsinki University Hospital
Aug 5, 2022
Aspirin-Sensitive Asthma With Nasal Polyps, Samter's Syndrome Trial in Charlottesville (Water, Red wine, Polyphenolic Compounds)
Unknown status
- Aspirin-Sensitive Asthma With Nasal Polyps
- Samter's Syndrome
- Water
- +2 more
-
Charlottesville, VirginiaUniversity of Virginia
May 1, 2018